Gilead Sciences Inc (GILD)
106.74
-0.34
(-0.32%)
USD |
NASDAQ |
Mar 24, 16:00
106.40
-0.34
(-0.32%)
After-Hours: 06:35
Gilead Sciences Total Liabilities (Quarterly): 39.75B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 85.96B |
| Johnson & Johnson | 108.61B |
| Eli Lilly and Co | 64.44B |
| Vertex Pharmaceuticals Inc | 6.124B |
| Moderna Inc | 3.241B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.00B |
| Shareholders Equity (Quarterly) | 19.33B |
| Debt to Equity Ratio | 1.382 |
| Current Ratio | 1.597 |
| Net Debt Paydown Yield | -0.30% |